Consecutive patients with advanced-stage acute leukemia (n=88) receiving HSCT from HLA-mismatched family donors during the same period (between January 2003 and March 2011) were enrolled in the study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results